This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential use of Thermo Fisher Scientific Inc's new blood test to detect women with risk of severe preeclampsia

Ticker(s): TMO

Who's the expert?

Institution: Yale School of Medicine

  • Obstetrics & Gynecology Specialist at Yale University
  • Served as Chairperson of the Obstetrics and Gynecology department at Milford Hospital and currently manages 10 patients monthly at risk for preeclampsia 
  • Research interest in predictors for perinatal outcomes

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many patients do you manage who are at risk for preeclampsia?

Added By: ben_admin
Q3.

What is the current gold standard for testing for preeclampsia?

Added By: ben_admin
Q4.

What are your thoughts on the test from Thermo Fisher?

Added By: ben_admin
Q5.

How do you interpret the tests sensitivity and specificity results?

Added By: ben_admin
Q6.

How many patients would you expect to order this test for in the first 6 months?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.